High CD147‐K148me2 levels were closely associated with poor overall survival in NSCLC patients, especially in patients with advanced‐stage NSCLC, possibly because of the high expression of NSD2 in this stage. The gene discussed is BSG; the disease is non-small cell lung carcinoma.